![](/img/cover-not-exists.png)
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study
Addison, Christina L., Pond, Gregory R., Cochrane, Brandy, Zhao, Huijun, Chia, Stephen K., Levine, Mark N., Clemons, MarkVolume:
4
Language:
english
Journal:
Journal of Bone Oncology
DOI:
10.1016/j.jbo.2015.04.001
Date:
June, 2015
File:
PDF, 1.13 MB
english, 2015